Alyeska Investment Group
EW icon

Alyeska Investment Group’s Edwards Lifesciences EW Stock Holding History

Alyeska Investment Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.5M Sell
812,860
-293,476
-27% -$24.6M 0.19% 150
2026
Q1 		$88.6M Buy
+1,106,336
New +$91.2M 0.25% 112
2025
Q1 		– Sell
-662,405
Closed -$49M – 559
2024
Q4 		$49M Buy
+662,405
New +$46.4M 0.18% 144
2020
Q4 		– Sell
-15,236
Closed -$1.22M – 537
2020
Q3 		$1.22M Buy
+15,236
New +$1.19M 0.02% 377
2020
Q2 		– Sell
-270,174
Closed -$17M – 512
2020
Q1 		$17M Buy
+270,174
New +$19.5M 0.34% 96
2018
Q2 		– Sell
-563,007
Closed -$26.2M – 480
2018
Q1 		$26.2M Buy
+563,007
New +$24.4M 0.22% 136
2017
Q3 		– Sell
-789,780
Closed -$31.1M – 483
2017
Q2 		$31.1M Sell
789,780
-570,627
-42% -$20.8M 0.26% 129
2017
Q1 		$42.7M Buy
+1,360,407
New +$42.6M 0.35% 100
2015
Q3 		– Sell
-31,410
Closed -$746K – 485
2015
Q2 		$746K Buy
+31,410
New +$709K 0.01% 428

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Alyeska Investment Group's EW Position: Q2 2026 in Review

Alyeska Investment Group reduced its Edwards Lifesciences (EW) stake by 27% in Q2 2026, selling an estimated $24.6M and leaving 812,860 shares worth $73.5M. The position accounts for 0.19% of the portfolio, ranked #150.

Alyeska Investment Group first reported a position in EW in Q2 2015 and has held it in 9 quarters since. The position peaked at $88.6M in Q1 2026. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Alyeska Investment Group held 812,860 shares of Edwards Lifesciences worth $73.5M as of Q2 2026.
  • Alyeska Investment Group sold 293,476 Edwards Lifesciences shares in Q2 2026, an estimated $24.6M.
  • Edwards Lifesciences made up 0.19% of Alyeska Investment Group's portfolio in Q2 2026, its #150 holding.
  • Alyeska Investment Group first reported a position in Edwards Lifesciences in Q2 2015 and has held it in 9 quarters since.
  • Alyeska Investment Group's Edwards Lifesciences position peaked at $88.6M in Q1 2026.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.